GlassScriptPhysician profile
Chris A Smiley
NPI 1689679946
$305,194.89
in general payments reported to CMS, 2019-2025
20 companies · $23K in 2025
The $23K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $27K · 2021: $44K · 2022: $44K · 2023: $53K · 2024: $56K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $87K · Travel and Lodging: $19K · Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,850 · Consulting Fee: $6,000 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $86,790.51 |
| Travel and Lodging | $19,221.81 |
| Food and Beverage | $10,950.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,849.75 |
| Consulting Fee | $6,000.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $135,158.18 | 2022-2025 | Infuse, Infuse Multifocal, Ultra Multifocal Toric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $86,314.50 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $37,452.06 | 2019-2025 | Cequa |
| Abbvie INC. | $21,723.20 | 2022-2025 | Vuity, Lumigan |
| Allergan, INC. | $11,461.81 | 2019-2022 | |
| Alcon Vision LLC | $5,360.95 | 2019-2025 | Dailies Total1, Precision7, Total30 |
| Coopervision INC. | $4,078.73 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,195.63 | 2019-2025 | Acuvue |
| Apellis Pharmaceuticals, INC. | $774.56 | 2024 | Syfovre |
| Oyster Point Pharma, INC. | $393.92 | 2022-2024 | Tyrvaya |
| Sight Sciences, INC. | $247.63 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $201.67 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $173.28 | 2021-2022 | |
| Visionary Optics LLC | $149.28 | 2023 | |
| Biotissue Holdings INC. | $142.86 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $137.91 | 2024-2025 | Vevye |
| Optovue, INC. | $116.66 | 2019 | |
| Lombart Brothers, INC. | $47.97 | 2019 | |
| Dompe US, INC. | $42.93 | 2021-2024 | Oxervate |
| Johnson & Johnson Health Care Systems INC. | $21.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Smiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.